Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Lack of Cisd2 disrupts calcium balance in cells, leading to poorly functioning neutrophils.

Targeting Vδ1+T-cells may help treat alopecia areata.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Hemp seed biomaterials may reduce hair loss and improve hair growth.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.